Dr. Ron Postuma outlines with Dr. Eduardo de Pablo-Fernández several advances this year he thinks will «revolutionize» Parkinson’s disease care, and shifts the field may need to make as a whole to help us reach the next phase of prodromal and personalized treatments.
Read MoreAs tic cases rise, Dr. Christos Ganos overviews with Dr. Hugo Morales two major treatment advancements, a growing emphasis on neurostimulation research and multidisciplinary care, and progress in the field’s largest area of opportunity.
Read MoreDr. Claudia Testa shares with Dr. Sara Schaefer why she believes in the quickly shifting field of tremor, we should be more open-minded about changes in diagnoses over time.
Read MoreAs genetics become more prominent in patient discussions, Professor Roy Alcalay outlines with Dr. Tiago Outeiro the key implications and opportunities as we enter «a different era of genetic testing.»
Read MoreThe lines between functional and organic are blurring, as a promising opportunity to develop outcome measurements arises. Dr. Alberto Espay discusses with Dr. Sara Schaefer these and other advancements in functional movement disorders.
Read MoreDespite the challenge of studying rare conditions like PSP, Dr. Yaroslau Compta discusses with Dr. Eduardo de Pablo-Fernández how leaps forward in recent advances could make us rethink the way we approach the condition.
Read MorePromising results on potential treatments, biomarkers, genetic predictors and more in dystonia were presented at the MDS Congress. Dr. Florence Chang highlights the key takeaways with Dr. Hugo Morales.
Read MoreWhich emerging areas of movement disorders research are set to advance in the coming years? And how is that already beginning to affect clinical care? Prof. Jose Obeso shares about this and other key scienctific shifts with Prof. Tiago Outeiro.
Read MoreNew updates to MSA criteria and clinical evaluation tools will have a critical impact on MSA care and research. Dr. Maria Teresa Pellecchia discusses with Dr. Eduardo de Pablo-Fernández the next major areas of focus, and the progression of a variety of clinical trials.
Read MoreMDS President Francisco Cardoso shares with Dr. Michele Matarazzo the important takeaways from this year’s Congress that will shape the future of movement disorders and the Society.
Read More